Less Ads, More Data, More Tools Register for FREE

Company Research

Filter Research Articles

Date TIDM Title Provider
10-Oct-24HERCTrading well ahead of expectationsEquity Development
10-Oct-24CAUCentaur Media - Tough trading backdrop persists in H2Edison
10-Oct-24USABaillie Gifford US Growth Trust - Seeking tomorrow’s mega capsEdison
10-Oct-24POLRH1 AUM +4% from quality manager with 8.6% yieldEquity Development
10-Oct-24MNY.USMoneyHero - Investing for the long termEdison
09-Oct-24UTLUIL - Announcement of 2028 privatisation plansEdison
09-Oct-24OSE.PAOSE Immunotherapeutics - Riding the H124 tailwindsEdison
09-Oct-24SPA1Spatial - Federal-level win in the USEdison
08-Oct-24IRLAB Therapeutics - IRL757 progress prompts $2.5m milestone p...Edison
08-Oct-24Synergistic acquisition of musicMagpieEquity Development
08-Oct-240LSECI Games - Strategic roadmap to 2028Edison
08-Oct-24LGRSTrading Update - Come rain or shine, Loungers deliversEquity Development
08-Oct-24IPXImpax AM: AUM +0.7% in Q4, -0.6% in FY24, dividend yield 7.4%Equity Development
07-Oct-24Actinogen Medical - Funding in place to complete XanaMIA Phase...Edison
07-Oct-24GAWGames Workshop Group - Sigmar the fourthEdison
07-Oct-24Datatec - Encouraging H1 across all divisionsEdison
04-Oct-24CARDCard Factory - Confident on FY25 outlookEdison
04-Oct-24IMMX.USImmix Biopharma - US CAR-T trial progresses to dose expansionEdison
03-Oct-24BrainStorm Cell Therapeutics (BCLI) Update Note 03102024ACF (Sponsored)
03-Oct-24HUWHelios Underwriting - Strategic shift from growth to consolid...Edison
03-Oct-24HOTHenderson Opportunities Trust - Taking AIM at the opportunityEdison
03-Oct-24IRLAB Therapeutics - IRL757 starts strong in Phase IEdison
03-Oct-24VP.Navigating market challenges, acquisition in IrelandEquity Development
03-Oct-24TFG.AMTetragon Financial Group - Tetragon maintains its investing paceEdison
02-Oct-24Cereno Scientific - CS1 shines in Phase IIa PAH trialEdison
02-Oct-24GRIDGresham House Energy Storage Fund - Rising revenues and big pl...Edison
02-Oct-24TPTTopps Tiles - Slight sequential improvement in Q424Edison
02-Oct-24INPPInternational Public Partnerships - FHSP partial realisation w...Edison
02-Oct-240RDBOryzon Genomics - FDA aligns on Phase III BPD plansEdison
01-Oct-24GRGGreggs - Good Q324 on strong comparativeEdison